t's quiet... Too quiet. Indeed, we've found ourselves in the "pre-showcase lull" for Xbox. Still, we have some big news to sift through. For starters, independent developers have thrived during the era of Xbox Game Pass thanks to massive bags being handed out for day one access which compliments the lower budgets of these titles. According to prominent indie developers, that gold rush is over. The Dukes dive into the future of Xbox Game Pass. If the way Xbox sells games is changing and the layoffs that have occurred all circle around the sustainability of the business, then there's no reality where Game Pass gets out unscathed. So, what are they changing, how do indies factor in, and what does it accomplish? Speaking of indies, it would see that Hollow Knight Silksong is finally on the way. When will this massive game land for Xbox and is it sooner than we expect? Plus, more on the questionable state of Final Fantasy 14, the future of KOTOR Remake, Dragon's Dogma 2's success, and so much more!

Please keep in mind that our timestamps are approximate, and will often be slightly off due to dynamic ad placement.

0:00:00 - Intro

0:15:03 - Final Fantasy 14's launch on Xbox is bad

0:19:47 - KOTOR Remake is alive and well

0:27:45 - Take Two now owns Gearbox

0:33:48 - Dragon's Dogma 2 has sold 2.5 million copies

0:36:11 - Details on the next Yakuza game

0:38:36 - Certain Affinity hit with layoffs

0:40:23 - Xbox has a new AI chatbot for support

0:46:02 - CD Projekt Red talks microtransactions

0:48:15 - What We're Playing

1:26:20 - Amy Hennig's Star Wars game

1:32:45 - Xbox's indie gold rush is over

1:46:32 - Hollow Knight Silksong coming soon?

1:50:33 - Coming to Xbox Game Pass

1:54:41 - Game Pass Pick Of The Week

2:01:46 - How to build the ultimate man cave

Learn more about your ad choices. Visit podcastchoices.com/adchoices

Podden och tillhörande omslagsbild på den här sidan tillhör Last Stand Media & Studio71. Innehållet i podden är skapat av Last Stand Media & Studio71 och inte av, eller tillsammans med, Poddtoppen.